Hamilton Thorne Ltd.

Equities

HTL

CA4078911001

Advanced Medical Equipment & Technology

End-of-day quote Toronto S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
1.4 ^CAD	+2.94%		+0.72%	+5.26%

May. 14	Hamilton Thorne Q1 Loss Widens Even as Sales Increase	MT
May. 14	Transcript : Hamilton Thorne Ltd., Q1 2024 Earnings Call, May 14, 2024

Hamilton Thorne Ltd. Opens the Market

September 21, 2023 at 11:29 am EDT

TORONTO, Sept. 21, 2023 /PRNewswire/ - David Wolf, Chairman and Chief Executive Officer, Hamilton Thorne Ltd. (TSX: HTL) joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation from TSX Venture Exchange to Toronto Stock Exchange.

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets.

CNW sponsored announcement. To learn more visit www.newswire.ca.

View original content to download multimedia:https://www.prnewswire.com/news-releases/hamilton-thorne-ltd-opens-the-market-301935147.html

SOURCE Toronto Stock Exchange

Latest news about Hamilton Thorne Ltd.

Hamilton Thorne Q1 Loss Widens Even as Sales Increase	May. 14	MT
Transcript : Hamilton Thorne Ltd., Q1 2024 Earnings Call, May 14, 2024	May. 14
Hamilton Thorne's Q4 Profit Falls, Sales Rise; Provides 2024 Outlook	Mar. 27	MT
Hamilton Thorne Brief: 2024 guidance is for a sales range between US$78 and $82 million representing 10-15% organic growth; Q1 guidance is for a sales range of $19.0 to $19.4 million	Mar. 27	MT
Hamilton Thorne Brief: Revenue of US$18.4 million for the 4th quarter; And Adj. EBITDA of $3.7 million for the quarter	Mar. 27	MT
Transcript : Hamilton Thorne Ltd., Q4 2023 Earnings Call, Mar 27, 2024	Mar. 27
Hamilton Thorne Ltd. Provides Earnings Guidance for the First Quarter 2024 and Full Twelve Months of 2024	Mar. 27	CI
Hamilton Thorne Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
North American Morning Briefing : Stocks Edge -2-	Mar. 27	DJ
Hamilton Thorne Maintained at Buy at Stifel GMP Ahead of Q4 Results; Price Target Kept at C$2.75	Mar. 26	MT
Hamilton Thorne Ltd. Announces Executive Changes, Effective January 15, 2024	Dec. 21	CI
Hamilton Thorne Ltd. Announces CEO Changes, Effective January 15, 2024	Dec. 21	CI
Hamilton Thorne Q3 Sales increased 16% YoY to US$15.7 Million	Nov. 13	MT
Hamilton Thorne Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Transcript : Hamilton Thorne Ltd., Q3 2023 Earnings Call, Nov 13, 2023	Nov. 13
Hamilton Thorne Brief: Q3 Sales increased 16% year over year to US$15.7 Million; Net loss was $785,000; After quarter end, Company Completed Aacquisition of Gynetics	Nov. 13	MT
North American Morning Briefing : Stock Futures Dip as Inflation Data Looms	Nov. 13	DJ
Hamilton Thorne Ltd. agreed to acquire Gynetics Medical Products N.V. for an enterprise value of ?18.3 million.	23-10-09	CI

Chart Hamilton Thorne Ltd.

Duration

Period

More charts

Company Profile

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-06-10 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Hamilton Thorne Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.026 USD

Average target price

1.667 USD

Spread / Average Target

+62.53%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
HAMILTON THORNE LTD.	+5.26%	157M
THERMO FISHER SCIENTIFIC	+12.79%	227B
DANAHER CORPORATION	+12.74%	192B
INTUITIVE SURGICAL, INC.	+16.64%	136B
BOSTON SCIENTIFIC CORPORATION	+28.89%	108B
SIEMENS HEALTHINEERS AG	+1.25%	64.07B
EDWARDS LIFESCIENCES CORPORATION	+17.46%	52.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.74%	51.87B
AGILENT TECHNOLOGIES, INC.	+9.97%	44.33B
GE HEALTHCARE TECHNOLOGIES INC.	+4.01%	36.75B

Other Advanced Medical Equipment & Technology